Search Results - Michael J. Nemeth

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Checkpoint immunotherapy is associated with preferential activation of tumor antigen–specific CD4+ T cells in MDS

    Checkpoint immunotherapy is associated with preferential activation of tumor antigen–specific CD4+ T cells in MDS by Elizabeth A. Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, Junko Matsuzaki, Kunle Odunsi, Laura W. Dillon, Devdeep Mukherjee, Christopher S. Hourigan, Jacqueline Peng, Shovik Bandyopadhyay, Kai Tan, Kristopher M. Attwood, Joseph B. Kuechle, Prashant K. Singh, Jianmin Wang, Michael J. Nemeth

    Published 2025-08-01

    Abstract: A growing body of literature suggests that the efficacy of DNA hypomethylating agents are mediated via activation of antitumor immune mechanisms. Based upon this hypothesis, early phase trials combining immune checkpoint inhibitors (ICIs) with azacitidine in patients with myelodysplastic s...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: